299 related articles for article (PubMed ID: 18841869)
1. Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation.
Astrahan M
Med Phys; 2008 Sep; 35(9):4161-72. PubMed ID: 18841869
[TBL] [Abstract][Full Text] [Related]
2. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
[TBL] [Abstract][Full Text] [Related]
3. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.
Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556
[TBL] [Abstract][Full Text] [Related]
4. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
[TBL] [Abstract][Full Text] [Related]
5. Obtaining organ-specific radiobiological parameters from clinical data for radiation therapy planning of head and neck cancers.
Quashie EE; Li XA; Prior P; Awan M; Schultz C; Tai A
Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37903437
[No Abstract] [Full Text] [Related]
6. Technical Note: Break-even dose level for hypofractionated treatment schedules.
Böhlen TT; Germond JF; Bourhis J; Vozenin MC; Bailat C; Bochud F; Moeckli R
Med Phys; 2021 Nov; 48(11):7534-7540. PubMed ID: 34609744
[TBL] [Abstract][Full Text] [Related]
7. Generalized Multi-Hit Model of Radiation-Induced Cell Survival with a Closed-Form Solution: An Alternative Method for Determining Isoeffect Doses in Practical Radiotherapy.
Zhao L; Chen X; Tian J; Shang Y; Mi D; Sun Y
Radiat Res; 2020 Apr; 193(4):359-371. PubMed ID: 32031917
[TBL] [Abstract][Full Text] [Related]
8. A comparative analysis of radiobiological models for cell surviving fractions at high doses.
Andisheh B; Edgren M; Belkić D; Mavroidis P; Brahme A; Lind BK
Technol Cancer Res Treat; 2013 Apr; 12(2):183-92. PubMed ID: 23098282
[TBL] [Abstract][Full Text] [Related]
9. On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model.
Unkel S; Belka C; Lauber K
Radiat Oncol; 2016 Jan; 11():11. PubMed ID: 26822015
[TBL] [Abstract][Full Text] [Related]
10. The radiobiology of hypofractionation.
Nahum AE
Clin Oncol (R Coll Radiol); 2015 May; 27(5):260-9. PubMed ID: 25797579
[TBL] [Abstract][Full Text] [Related]
11. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
[TBL] [Abstract][Full Text] [Related]
12. What hypofractionated protocols should be tested for prostate cancer?
Fowler JF; Ritter MA; Chappell RJ; Brenner DJ
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1093-104. PubMed ID: 12829147
[TBL] [Abstract][Full Text] [Related]
13. Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (Review).
Franken NA; Oei AL; Kok HP; Rodermond HM; Sminia P; Crezee J; Stalpers LJ; Barendsen GW
Int J Oncol; 2013 May; 42(5):1501-15. PubMed ID: 23503754
[TBL] [Abstract][Full Text] [Related]
14. Modelling the impact of fractionation on late urinary toxicity after postprostatectomy radiation therapy.
Fiorino C; Cozzarini C; Rancati T; Briganti A; Cattaneo GM; Mangili P; Di Muzio NG; Calandrino R
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1250-7. PubMed ID: 25442349
[TBL] [Abstract][Full Text] [Related]
15. Applicability of the linear-quadratic model to single and fractionated radiotherapy schedules: an experimental study.
Miyakawa A; Shibamoto Y; Otsuka S; Iwata H
J Radiat Res; 2014 May; 55(3):451-4. PubMed ID: 24351457
[TBL] [Abstract][Full Text] [Related]
16. Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters.
Borst GR; Ishikawa M; Nijkamp J; Hauptmann M; Shirato H; Bengua G; Onimaru R; de Josien Bois A; Lebesque JV; Sonke JJ
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1596-603. PubMed ID: 20231066
[TBL] [Abstract][Full Text] [Related]
17. Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart.
Appelt AL; Vogelius IR; Bentzen SM
Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):147-52. PubMed ID: 22910644
[TBL] [Abstract][Full Text] [Related]
18. A unified multi-activation (UMA) model of cell survival curves over the entire dose range for calculating equivalent doses in stereotactic body radiation therapy (SBRT), high dose rate brachytherapy (HDRB), and stereotactic radiosurgery (SRS).
Li S; Miyamoto C; Wang B; Giaddui T; Micaily B; Hollander A; Weiss SE; Weaver M
Med Phys; 2021 Apr; 48(4):2038-2049. PubMed ID: 33590493
[TBL] [Abstract][Full Text] [Related]
19. A challenge to traditional radiation oncology.
Fowler JF; Tomé WA; Fenwick JD; Mehta MP
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1241-56. PubMed ID: 15519797
[TBL] [Abstract][Full Text] [Related]
20. Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study.
Iwata H; Shibamoto Y; Murata R; Tomita N; Ayakawa S; Ogino H; Ito M
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):482-8. PubMed ID: 19735872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
